Mesa Laboratories (MLAB)
(Delayed Data from NSDQ)
$62.01 USD
+4.57 (7.96%)
Updated Aug 6, 2025 04:00 PM ET
After-Market: $63.66 +1.65 (2.66%) 7:30 PM ET
5-Strong Sell of 5 5
A Value B Growth A Momentum A VGM
Fundamental Charts
About Cash from Investing (Quarterly)
The company's quarterly Cash from Investing value is the sum of the company's current quarter cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
MLAB 62.01 +4.57(7.96%)
Will MLAB be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for MLAB based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for MLAB
Mesa Labs (MLAB) Lags Q1 Earnings and Revenue Estimates
Mettler-Toledo (MTD) Q2 Earnings and Revenues Top Estimates
MLAB: What are Zacks experts saying now?
Zacks Private Portfolio Services
Mesa Labs (MLAB) Q4 Earnings and Revenues Lag Estimates
Sensus Healthcare, Inc. (SRTS) Reports Q1 Loss, Tops Revenue Estimates
Steris (STE) Surpasses Q4 Earnings Estimates
Other News for MLAB
12 Health Care Stocks Moving In Tuesday's Intraday Session
MLAB Reports Q1 Revenue Below Expectations Amid Economic Challenges
Mesa Labs Announces First Quarter Results | MLAB Stock News
Mesa Laboratories Inc (MLAB) Q1 Earnings: EPS of $0.85 Surpasses Estimates, Revenue at $59. ...
Mesa Laboratories GAAP EPS of $0.85 beats by $0.41, revenue of $59.54M misses by $1.03M